Patents by Inventor Michel Tardy

Michel Tardy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8016120
    Abstract: The invention relates to a method for obtaining viruses from a liquid viral suspension, according to which: the viral suspension is subjected to density gradient ultracentrifugation, the ultracentrifugation is carried out continuously, and the density gradient is a discontinuous gradient comprising at least 2 steps.
    Type: Grant
    Filed: June 25, 2008
    Date of Patent: September 13, 2011
    Assignee: Sanofi Pasteur SA
    Inventors: Olivier Brass, Jean-Marc Contzen, Alain Francon, Michel Tardy
  • Publication number: 20090023197
    Abstract: The invention relates to a method for obtaining viruses from a liquid viral suspension, according to which: the viral suspension is subjected to density gradient ultracentrifugation, the ultracentrifugation is carried out continuously, and the density gradient is a discontinuous gradient comprising at least 2 steps.
    Type: Application
    Filed: June 25, 2008
    Publication date: January 22, 2009
    Applicant: SANOFI PASTEUR SA
    Inventors: Oliver Brass, Jean Marc Contzen, Alain Francon, Michel Tardy
  • Patent number: 6391939
    Abstract: The present invention relates to a biocompatible collagenous material which is non-toxic and biodegradable in less than one month, preferably in less than one week. This material comprises collagen and at least one hydrophilic macromolecular additive which is chemically non-reactive towards the collagen, with the collagen having at least partially lost its helical structure and being crosslinked. The invention also relates to a process for obtaining such a material. The collagenous material according to the invention is used, in particular, for preventing post-operative adhesions.
    Type: Grant
    Filed: August 5, 1999
    Date of Patent: May 21, 2002
    Assignee: Imedex Biomateriaux
    Inventors: Jean-Louis Tayot, Michel Tardy, Philippe Gravagna
  • Publication number: 20010008930
    Abstract: The present invention relates to a biocompatible collagenous material which is non-toxic and biodegradable in less than one month, preferably in less than one week. This material comprises collagen and at least one hydrophilic macromolecular additive which is chemically non-reactive towards the collagen, with the collagen having at least partially lost its helical structure and being crosslinked.
    Type: Application
    Filed: August 5, 1999
    Publication date: July 19, 2001
    Inventors: JEAN-LOUIS TAYOT, MICHEL TARDY, PHILIPPE GRAVAGNA
  • Patent number: 6165488
    Abstract: A biocompatible, bioresorbable and nontoxic adhesive composition for surgical and/or therapeutic use, especially for the bonding of biological tissues to one another or to an implanted biomaterial, is provided which comprises at least one biodegradable macromolecular polyaldehyde of natural origin in aqueous solution and a collagen-based component dissolved in aqueous medium. A process for preparing this composition is also provided wherein these aqueous components are mixed together (e.g., at neutral, physiological pH) to give a gel which is rapidly applied to tissues and/or biomaterial to achieve binding. The present invention is advantageous in that it provides biodegradable macromolecular polyaldehydes with adhesive properties and the ability to be extremely well tolerated by the recipient while retaining their adhesive properties during their retention in the body.
    Type: Grant
    Filed: June 8, 1998
    Date of Patent: December 26, 2000
    Assignee: Societe Anonyme de Developpement des Utilisations du Collagene S.A.D.U.C.
    Inventors: Michel Tardy, Herve Volckmann, Jerome Tiollier, Philippe Gravagna, Jean-Louis Tayot
  • Patent number: 5654135
    Abstract: Biomaterial based on collagen comprises, intimately associated, a support forming a dermal substitute, said support comprising a layer based on type IV collagen and an epidermal epithelium having differentiated cells obtained by growing epidermal cells on said support.
    Type: Grant
    Filed: June 19, 1995
    Date of Patent: August 5, 1997
    Assignees: Imedex, societe anonyme, Pasteur Merieux Serums et Vaccins, societe anonyme
    Inventors: Estelle Tinois, Jerome Tiollier, Henri Dumas, Michel Tardy
  • Patent number: 5618551
    Abstract: The invention relates to a biocompatible, bioresorbable and non-toxic adhesive composition for surgical use, for the bonding, in particular, of biological tissues to one another or in an implanted biomaterial, characterized in that it comprises a reactive acidic solution of non-crosslinked and potentially crosslinkable collagen or gelatin modified by oxidative cleavage, at a concentration which is preferably between approximately 5 and 30 by weight. It also relates to reactive acidic solutions and powders based on non-crosslinked collagen or gelatin modified by oxidative cleavage which are used as intermediate products in the preparation of the above-mentioned composition, and to the process for their preparation. It also relates to adhesive kits which comprise, on the one hand, the above-mentioned reactive acidic solution and, on the other hand, a neutralizing solution and which are intended for extemporaneous mixing.
    Type: Grant
    Filed: January 20, 1995
    Date of Patent: April 8, 1997
    Assignee: Imedex
    Inventors: Michel Tardy, J er ome Tiollier, Jean-Louis Tayot
  • Patent number: 5436135
    Abstract: Human or animal placenta is subjected to moderate enzymatic digestion, in particular with pepsin at an acid pH, then, after separation of the residual tissue the impurities are separated at a moderately acid pH, the collagen is precipitated at a neutral pH, redissolved and the residual impurities precipitated at an acid pH. The collagen obtained can be brought back to a neutral pH and dried in the form of fibres. Completely transparent, physiological and hemocompatible gels and solutions can be prepared. Applications for the fabrication of contact lenses and implants.
    Type: Grant
    Filed: January 7, 1991
    Date of Patent: July 25, 1995
    Assignees: Pasteur Merieux Serums et Vaccins, Imedex
    Inventors: Jean-Louis Tayot, Michel Tardy
  • Patent number: 5234991
    Abstract: A porous mineral support such as a porous mineral oxide coated with an aminated polysaccharide polymer has cationic characteristics and is capable of reversibly fixing thereto biological macromolecules. This material is employed in the separation and purification of said biologic macromolecules.
    Type: Grant
    Filed: March 17, 1987
    Date of Patent: August 10, 1993
    Assignee: Pasteur Merieux Serums and Vaccines
    Inventors: Jean-Louis Tayot, Michel Tardy
  • Patent number: 5201745
    Abstract: A patch for visceral surgery is made from a biomaterial consisting of two layers of collagen superimposed and closely combined, namely a porous adhesive layer of fibrous collagen and a film of collagen and/or gelatin.
    Type: Grant
    Filed: August 15, 1991
    Date of Patent: April 13, 1993
    Assignee: Imedex
    Inventors: Jean-Louis Tayot, Jacques Marescaux, Henri Dumas, Michel Tardy
  • Patent number: 4931546
    Abstract: Collagen is submitted to a controlled oxidation by treatment with a solution of periodic acid or of a periodate, notably of sodium. Application to gels, implants, lenses, films, spheres, etc., of collagen.
    Type: Grant
    Filed: July 13, 1987
    Date of Patent: June 5, 1990
    Assignees: Imedex, Institut Merieux
    Inventors: Michel Tardy, Jean-Louis Tayot
  • Patent number: 4764279
    Abstract: The process comprises subjecting the hemolyzed blood to a clarification step at a pH of between 4 and 6 in the presence of less than 15% of alcohol, then, after concentration, effecting a chromatography by exchange of anions so as to separate the hemoglobin, the albumin being thereafter eluted. The hemoglobin and the globulins may then be separated out by precipitation with 25% alcohol at a pH of 7. The proteins obtained are in the native state.
    Type: Grant
    Filed: June 13, 1986
    Date of Patent: August 16, 1988
    Assignee: Institut Merieux
    Inventors: Jean L. Tayot, Paule A. Gattel, Michel A. Tardy
  • Patent number: 4675384
    Abstract: The plasma proteins contained in a plasma solution thereof are chromatographically fractioned, e.g., to obtain a high purity therapeutic grade albumin product, by successively contacting said plasma solution with at least one anion exchanger and at least one cation exchanger in fixed bed chromatography columns, the contact and exchange medium of chromatography therein also comprising a plurality of at least partially hydrophobic support particulates and a plurality of hydrophilic ion exchanger support particulates.
    Type: Grant
    Filed: April 2, 1984
    Date of Patent: June 23, 1987
    Assignees: Rhone-Poulenc Recherches, Institut Merieux
    Inventors: Adrien Dromard, Michel Exertier, Claude Rollin, Jean-Louis Tayot, Michel Tardy
  • Patent number: 4673734
    Abstract: A porous mineral support such as a porous mineral oxide coated with an aminated polysaccharide polymer has cationic characteristics and is capable of reversibly fixing thereto biological macromolecules. This material is employed in the separation and purification of said biologic maromolecules.
    Type: Grant
    Filed: March 21, 1985
    Date of Patent: June 16, 1987
    Assignee: Institut Merieux
    Inventors: Jean-Louis Tayot, Michel Tardy
  • Patent number: 4308254
    Abstract: A process for preparing a porous solid material for use in a chromatography column and which is capable of fixing reversibly biological macromolecules comprises coating a porous inorganic support with a polysaccharide polymer having .alpha.-glycol groups which undergo oxidative scission, subjecting the polysaccharide polymer to an oxidative scission reaction, reacting the resulting oxidized polysaccharide polymer with an amino molecule or macromolecule having the formula R'--NH.sub.2 to produce a polysacchride polymer having the formula R.sub.4 --CH.dbd.N--R' and reducing the imine bond in said immediately above defined polysaccharide polymer to a stable amine bond.
    Type: Grant
    Filed: September 19, 1978
    Date of Patent: December 29, 1981
    Assignee: Institut Merieux
    Inventors: Jean-Louis Tayot, Michel Tardy